Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations.

Mutagonda RF, Minzi OMS, Massawe SN, Asghar M, Färnert A, Kamuhabwa AAR, Aklillu E.

Drug Metab Dispos. 2019 Dec;47(12):1415-1424. doi: 10.1124/dmd.119.088062.

PMID:
31744845
2.

Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype.

Kitabi EN, Minzi OMS, Mugusi S, Sasi P, Janabi M, Mugusi F, Bertilsson L, Burhenne J, Aklillu E.

Sci Rep. 2018 Nov 5;8(1):16316. doi: 10.1038/s41598-018-34674-3.

3.

Efficacy of standardized extract of Hibiscus sabdariffa L. (Malvaceae) in improving iron status of adults in malaria endemic area: A randomized controlled trial.

Peter EL, Rumisha SF, Mashoto KO, Minzi OM, Mfinanga S.

J Ethnopharmacol. 2017 Sep 14;209:288-293. doi: 10.1016/j.jep.2017.07.037. Epub 2017 Jul 26.

PMID:
28755971
4.

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.

Mutagonda RF, Kamuhabwa AAR, Minzi OMS, Massawe SN, Asghar M, Homann MV, Färnert A, Aklillu E.

Malar J. 2017 Jul 3;16(1):267. doi: 10.1186/s12936-017-1914-9.

5.

Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.

Mutagonda RF, Kamuhabwa AA, Minzi OM, Massawe SN, Maganda BA, Aklillu E.

Malar J. 2016 May 13;15(1):278. doi: 10.1186/s12936-016-1327-1.

6.

Safety Profile of Artemether-Lumefantrine: A Cohort Event Monitoring Study in Public Health Facilities in Tanzania.

Mssusa AK, Fimbo AM, Nkayamba AF, Irunde HF, Sillo HB, Shewiyo DH, Hill G, Minzi OM.

Clin Drug Investig. 2016 May;36(5):401-11. doi: 10.1007/s40261-016-0385-z.

PMID:
26951203
7.

CYP2B6*6 genotype and high efavirenz plasma concentration but not nevirapine are associated with low lumefantrine plasma exposure and poor treatment response in HIV-malaria-coinfected patients.

Maganda BA, Minzi OM, Ngaimisi E, Kamuhabwa AA, Aklillu E.

Pharmacogenomics J. 2016 Feb;16(1):88-95. doi: 10.1038/tpj.2015.37. Epub 2015 May 12.

PMID:
25963334
8.
9.

Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.

Marwa KJ, Schmidt T, Sjögren M, Minzi OM, Kamugisha E, Swedberg G.

Malar J. 2014 Nov 3;13:420. doi: 10.1186/1475-2875-13-420.

10.

Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy.

Maganda BA, Minzi OM, Kamuhabwa AA, Ngasala B, Sasi PG.

Malar J. 2014 May 30;13:205. doi: 10.1186/1475-2875-13-205.

11.
12.

Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product.

Minzi OM, Marealle IA, Shekalaghe S, Juma O, Ngaimisi E, Chemba M, Rutaihwa M, Abdulla S, Sasi P.

Malar J. 2013 May 30;12:174. doi: 10.1186/1475-2875-12-174.

13.

Application of basic pharmacology and dispensing practice of antibiotics in accredited drug-dispensing outlets in Tanzania.

Minzi O, Manyilizu V.

Drug Healthc Patient Saf. 2013;5:5-11. doi: 10.2147/DHPS.S36409. Epub 2013 Jan 30.

14.

Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania.

Joseph D, Kabanywanyi AM, Hulser R, Premji Z, Minzi OM, Mugittu K.

Malar J. 2013 Feb 11;12:60. doi: 10.1186/1475-2875-12-60.

15.

Self-initiation of antiretroviral therapy in the developing world: the involvement of private pharmacies in an HIV program.

Minzi OM, Buma D, Kagashe GA.

Drug Healthc Patient Saf. 2012;4:27-31. doi: 10.2147/DHPS.S23653. Epub 2012 Mar 29.

16.

Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.

Mugusi SF, Ngaimisi E, Janabi MY, Mugusi FM, Minzi OM, Sasi PG, Bakari M, Lindquist L, Aklillu E, Sandstrom EG.

Antivir Ther. 2012;17(2):265-74. doi: 10.3851/IMP1956. Epub 2011 Nov 17.

PMID:
22293579
17.

Correlation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patients.

Minzi O, Mugoyela V, Gustafsson L.

Ther Clin Risk Manag. 2011;7:441-6. doi: 10.2147/TCRM.S23625. Epub 2011 Nov 22.

18.

Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients.

Ngaimisi E, Mugusi S, Minzi OM, Sasi P, Riedel KD, Suda A, Ueda N, Janabi M, Mugusi F, Haefeli WE, Burhenne J, Aklillu E.

Clin Pharmacol Ther. 2010 Nov;88(5):676-84. doi: 10.1038/clpt.2010.172. Epub 2010 Sep 29.

PMID:
20881953
19.

HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania.

Minzi OM, Irunde H, Moshiro C.

Tanzan J Health Res. 2009 Jan;11(1):5-10.

PMID:
19445098
22.

Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered.

Minzi OM, Gupta A, Haule AF, Kagashe GA, Massele AY, Gustafsson LL.

Eur J Clin Pharmacol. 2007 May;63(5):457-62. Epub 2007 Feb 27.

PMID:
17333157
23.

Existence of antimalarial formulations with low bioavailability in Tanzania.

Minzi OM, Massele A, Justin-Temu M, Ericsson O, Gustafsson LL.

Trop Doct. 2006 Apr;36(2):93-7.

PMID:
16611442
24.

Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community.

Eriksen J, Nsimba SE, Minzi OM, Sanga AJ, Petzold M, Gustafsson LL, Warsame MY, Tomson G.

Trop Med Int Health. 2005 Oct;10(10):1038-46.

25.

Simple and cost-effective liquid chromatographic method for determination of pyrimethamine in whole blood samples dried on filter paper.

Minzi OM, Massele AY, Gustafsson LL, Ericsson O.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 5;814(1):179-83.

PMID:
15607723
26.

Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania.

Minzi OM, Moshi MJ, Hipolite D, Massele AY, Tomson G, Ericsson O, Gustafsson LL.

J Clin Pharm Ther. 2003 Apr;28(2):117-22.

PMID:
12713608
27.

High-performance liquid chromatographic method for determination of amodiaquine, chloroquine and their monodesethyl metabolites in biological samples.

Minzi OM, Rais M, Svensson JO, Gustafsson LL, Ericsson O.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 15;783(2):473-80.

PMID:
12482490

Supplemental Content

Loading ...
Support Center